SCHEMBL22308653

SCHEMBL22308653

c1ccc(-c2nc(-c3cccc(-c4cccc(-c5nc(-c6ccccc6)nc(-c6cccc7c6oc6ccccc67)n5)c4)c3)cc(-c3ccc4ccccc4c3)n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.43
CYP1A1 P04798 1/20 0.41
CYP1B1 Q16678 1/20 0.41
ALDH1A1 P00352 7/20 0.40
MAPT P10636 7/20 0.40
MEN1 O00255 5/20 0.40
KMT2A Q03164 5/20 0.40
KDM4E B2RXH2 5/20 0.40
HPGD P15428 4/20 0.40
LMNA P02545 2/20 0.40
GLA P06280 1/20 0.40
CYP1A2 P05177 2/20 0.38
TP53 P04637 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
HSD17B10 Q99714 2/20 0.38
PIM1 P11309 1/20 0.38
POLB P06746 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
GGPS1 O95749 1/20 0.35
NTSR1 P30989 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22309595 0.97 ALOX5 (0.44) ALOX5CYP1A1CYP1B1ALDH1A1MAPT
SCHEMBL22889372 0.94 ALOX5 (0.45) ALOX5ALDH1A1MAPTMEN1KMT2A
SCHEMBL22889256 0.94 ALOX5 (0.45) ALOX5ALDH1A1MAPTMEN1KMT2A
SCHEMBL19397495 0.93 CYP1A1 (0.46) ALOX5CYP1A1CYP1B1ALDH1A1MAPT
SCHEMBL22889267 0.93 ALOX5 (0.46) ALOX5ALDH1A1MAPTMEN1KMT2A
SCHEMBL22889401 0.93 ALOX5 (0.46) ALOX5ALDH1A1MAPTMEN1KMT2A
SCHEMBL22889379 0.93 ALOX5 (0.46) ALOX5ALDH1A1MAPTMEN1KMT2A
SCHEMBL22889107 0.93 ALOX5 (0.48) ALOX5CYP1A1CYP1B1ALDH1A1MAPT
SCHEMBL15501748 0.93 ALOX5 (0.48) ALOX5ALDH1A1MAPTMEN1KMT2A
SCHEMBL22309543 0.92 ALOX5 (0.45) ALOX5ALDH1A1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11917910-B2 Organic compound and organic electroluminescent device using the same SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2024-02-27 US disclosed
US-11917910-B2 Organic compound and organic electroluminescent device using the same SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2024-02-27 US disclosed
US-20200251659-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME DOOSAN CORPORATION (KR) 2020-08-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200251659-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME VDAC1, OR10J3, PIEZO1 ALOX5 775/4885CYP1A1 1223/4885CYP1B1 2080/4885
US-11917910-B2 Organic compound and organic electroluminescent device using the same VDAC1, OR10J3, PIEZO1 ALOX5 775/4885CYP1A1 1223/4885CYP1B1 2080/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.